PTX3 and endothelial dysfunction: We found that the expected improvement in endothelial dysfunction was accompanied by a significant reduction in the inflammatory markers hsCRP and PTX3, oxidative stress marker MDA and anti-atherosclerotic marker ADMA, the change in which both correlated independently with an observed improvement in ultrasonographically measured FMD.